We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4B
AUM Growth
-$1.25B
(-24%)
Cap. Flow
-$1.28B
Cap. Flow
% of AUM
-32.02%
Top 10 Holdings %
Top 10 Hldgs %
20.82%
Holding
1,612
New
626
Increased
195
Reduced
208
Closed
487
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$10.2M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$6.08M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$5.95M |
| 4 |
Biogen
BIIB
|
+$5.94M |
| 5 |
Aon
AON
|
+$5.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$294M |
| 2 |
Lennar Class A
LEN
|
+$76.3M |
| 3 |
RH
RH
|
+$25.1M |
| 4 |
ARK Genomic Revolution ETF
ARKG
|
+$22.5M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.79% |
| 2 | Communication Services | 1.57% |
| 3 | Technology | 1.13% |
| 4 | Consumer Discretionary | 1.05% |
| 5 | Financials | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLP
526
DELISTED
Cantaloupe
CTLP
| $1.3M | 0.03% |
+111,319
| New | +$1.17M |
|
527
PUT
Coca-Cola Europacific Partners
CCEP
$49.1B
| $1.3M | 0.03% |
25,000
| – | – |
|
528
CALL
Nektar Therapeutics
NKTR
$2.39B
| $1.3M | 0.03% |
4,333
+1,833
| +73% | +$571K |
|
529
PUT
Ionis Pharmaceuticals
IONS
$8.93B
| $1.29M | 0.03% |
+28,800
| New | +$1.61M |
|
530
CALL
Ascendis Pharma A/S
ASND
$16.5B
| $1.29M | 0.03% |
+10,000
| New | +$1.52M |
|
|
531
PUT
Ascendis Pharma A/S
ASND
$16.5B
| $1.29M | 0.03% |
+10,000
| New | +$1.52M |
|
532
CALL
Merck
MRK
$322B
| $1.29M | 0.03% |
17,502
-63,928
| -79% | -$4.72M |
|
|
TVRD
533
PUT
Tvardi Therapeutics
TVRD
$20.1M
| $1.28M | 0.03% |
+1,644
| New | +$1.13M |
|
|
PAE
534
CALL
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $1.26M | 0.03% |
+140,000
| New | +$1.25M |
|
535
CALL
Sabre
SABR
$716M
| $1.26M | 0.03% |
85,000
-140,000
| -62% | -$1.9M |
|
536
DexCom
DXCM
$29B
| $1.26M | 0.03% |
+14,000
| New | +$1.31M |
|
537
CALL
Skillsoft
SKIL
$66.3M
| $1.25M | 0.03% |
+6,250
| New | +$1.28M |
|
|
GLUU
538
CALL
DELISTED
Glu Mobile Inc.
GLUU
| $1.25M | 0.03% |
+100,000
| New | +$1.11M |
|
539
CALL
MarketAxess Holdings
MKTX
$4.47B
| $1.25M | 0.03% |
2,500
| – | – |
|
540
CALL
Celularity
CELU
$19.4M
| $1.24M | 0.03% |
+12,330
| New | +$1.26M |
|
|
CAN
541
CALL
Canaan Creative
CAN
$172M
| $1.24M | 0.03% |
+60,100
| New | +$895K |
|
542
Varonis Systems
VRNS
$4.67B
| $1.23M | 0.03% |
+24,000
| New | +$1.42M |
|
543
CALL
PG&E
PCG
$39B
| $1.23M | 0.03% |
105,000
-135,000
| -56% | -$1.57M |
|
544
Antero Resources
AR
$10.9B
| $1.22M | 0.03% |
120,000
+7,500
| +7% | +$63.5K |
|
545
CALL
Momentus
MNTS
$78.4M
| $1.22M | 0.03% |
+7
| New | +$1.68M |
|
546
CALL
SLB Ltd
SLB
$72.7B
| $1.22M | 0.03% |
45,000
-78,000
| -63% | -$2.05M |
|
|
CMRC
547
Commerce.com Inc Series 1
CMRC
$272M
| $1.21M | 0.03% |
21,000
+9,000
| +75% | +$598K |
|
|
SCPL
548
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $1.21M | 0.03% |
+75,000
| New | +$1.29M |
|
|
VMW
549
DELISTED
VMware, Inc
VMW
| $1.2M | 0.03% |
+8,000
| New | +$1.14M |
|
550
CALL
ARK Innovation ETF
ARKK
$5.59B
| $1.2M | 0.03% |
10,000
-57,000
| -85% | -$7.71M |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q1 2021 Portfolio in Review
As of Q1 2021, SG3 Management held 1,612 positions worth $4B, down 24% from $5.25B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
SG3 Management withdrew a net $1.28B in Q1 2021, closing 487 positions and reducing 208 holdings. Its most notable exit was Amazon, an estimated $294M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 0.67% a quarter earlier, followed by Communication Services and Technology.
Against the trend, SG3 Management opened a new position in Albemarle worth $4.16M.
- SG3 Management's largest Q1 2021 buy was Albemarle: 28,500 shares worth $4.16M.
- SG3 Management added most to Jazz Pharmaceuticals in Q1 2021, an estimated $10.2M increase.
- SG3 Management's biggest Q1 2021 reduction was RH, cutting an estimated $25.1M.
- SG3 Management fully exited Amazon in Q1 2021, selling an estimated $294M.
- SG3 Management's ten largest holdings make up 21% of its $4B portfolio in Q1 2021.
- SG3 Management opened 626 new positions and closed 487 in Q1 2021.
- SG3 Management's portfolio value fell 24% quarter-over-quarter to $4B.
Based on SG3 Management's 13F filing for Q1 2021, filed 17 May 2021.